Atypical Gastric Lesion Revealing Underlying Pancreatic Cancer With Direct Invasion

Article information

Korean J Helicobacter Up Gastrointest Res. 2025;25(3):288-291
Publication date (electronic) : 2025 September 1
doi : https://doi.org/10.7704/kjhugr.2025.0032
Department of Internal Medicine, Semyeong Christianity Hospital, Pohang, Korea
Corresponding author Byeong Joo Jo, MD Department of Internal Medicine, Semyeong Christianity Hospital, 351 Posco-daero, Nam-gu, Pohang 37816, Korea E-mail: jam1124@naver.com
Received 2025 May 12; Revised 2025 June 11; Accepted 2025 June 29.

Abstract

Atypical gastric lesions present diagnostic challenges, particularly when they mimic benign conditions. We report the case of a 76-year-old male who underwent esophagogastroduodenoscopy (EGD) during routine screening. The EGD revealed a 1-cm ulcerative lesion in the lesser curvature of the stomach. The initial endoscopic report simply described the lesion as a “gastric ulcer,” and the initial biopsy indicated a tubulovillous adenoma with low-grade dysplasia. However, follow-up endoscopy demonstrated an irregular, non-healing ulcer without a clean base, raising a strong possibility of deeper infiltration. A follow-up biopsy showed atypical findings, suggestive of malignancy, and prompting further evaluation. Abdominal computed tomography (CT) revealed a mass in the pancreatic body and tail that directly invaded the gastric wall, along with extensive peritoneal metastasis. Positron emission tomography-CT confirmed hypermetabolic activity in the pancreatic lesion. The final diagnosis was a pancreatic adenocarcinoma with gastric invasion. This case highlights the importance of correlating endoscopic findings with imaging and pathology findings, especially when endoscopic morphology appears atypical and inconsistent with biopsy results. Repeat evaluations and cross-sectional imaging may prevent unnecessary procedures and allow timely identification of extrinsic malignancies that present as primary gastric lesions.

INTRODUCTION

Pancreatic cancer is among the most aggressive gastrointestinal malignancies, often diagnosed at an advanced stage. It has a high mortality rate due to late diagnosis [1]. Common metastatic sites include lymph nodes, liver, lungs, and peritoneum, with gastric involvement being exceedingly rare [2]. Differentiating between primary gastric lesions and secondary invasion by pancreatic cancer is clinically challenging, especially when endoscopic appearances mimic benign pathology [3]. Herein, we report a case in which pancreatic cancer initially presented with endoscopic features suggestive of a benign gastric adenoma.

CASE REPORT

A 76-year-old male underwent screening esophagogastroduodenoscopy, revealing a 1 cm ulcerative lesion (Fig. 1) on the lesser curvature of the stomach. The initial endoscopic report described the lesion merely as a gastric ulcer and two biopsy specimens were obtained which indicated tubulovillous adenoma with low-grade dysplasia.

Fig. 1.

Initial screening esophagogastroduodenoscopy. A 1-cm ulcerative lesion with whitish exudate and central depression is noted on the lesser curvature of the upper gastric body.

He was referred to our department for further management. He reported mild abdominal fullness and had central obesity, but no abdominal tenderness or signs of peritoneal irritation were noted on physical examination.

Although the initial endoscopic report described the lesion simply as a gastric ulcer, its irregular margins and granular surface raised the possibility of early gastric cancer, and endoscopic submucosal dissection (ESD) was initially planned. Routine laboratory tests revealed no anemia (hemoglobin 14.2 g/dL), no hypoalbuminemia (albumin 3.7 g/dL), and normal liver and renal function. Tumor marker showed elevated carcinoembryonic antigen (CEA) at 23.0 ng/mL (normal <2.5 ng/mL), while alpha-fetoprotein and carbohydrate antigen 19-9 (CA 19-9) were within normal limits. Colonoscopy was performed to rule out colorectal neoplasia and confirmed only benign tubular adenomas.

A second-look endoscopy revealed an irregular, non-healing ulcer without a clean base. Notably, muscle fibers consistent with the muscularis propria layer were directly exposed at the ulcer base, raising strong concern for deep infiltration. Additional findings such as mucosal friability and spontaneous oozing further heightened suspicion of malignancy (Fig. 2), leading to cancellation of ESD.

Fig. 2.

Detailed endoscopic view using cap-fitted endoscope. Central ulceration with surrounding erythema and friable mucosa. Second-look esophagogastroduodenoscopy reveals deeper ulceration with irregular borders and mucosal disruption suggestive of fistulization.

Re-biopsy showed atypical findings such as irregular, infiltrative glands embedded in a desmoplastic stroma, cribriform architecture, nuclear pleomorphism, hyperchromasia, and loss of polarity—suggestive of malignancy (Fig. 3), prompting further evaluation. An abdominal CT was performed, revealing an ill-defined mass in the pancreatic body and tail (Fig. 4) with main pancreatic duct dilatation and direct invasion into the gastric wall. Additionally, massive ascites and peritoneal carcinomatosis were noted. Positron emission tomography-CT (PET-CT) confirmed hypermetabolic activity in the pancreatic lesion (Fig. 5) [4].

Fig. 3.

Histopathologic examination of the gastric biopsy specimen (H&E stain). A: Irregular infiltrating glands with desmoplastic stroma (×200). B: Densely packed, irregularly branching glandular structures (×200). C: Cribriform patterns of malignant glandular formation (×200). D: Tumor cells showing nuclear hyperchromasia, pleomorphism, and loss of polarity (×400).

Fig. 4.

Contrast-enhanced abdominal computed tomography. Axial view showing an ill-defined hypodense mass in the pancreatic body invading the lesser curvature of the stomach. Coronal view reveals extensive peritoneal carcinomatosis and ascites.

Fig. 5.

Positron emission tomography-computed tomography (PET-CT). Axial fused PET-CT images show intense fluorodeoxyglucose uptake in the pancreatic mass and multiple peritoneal foci.

Ascitic fluid analysis demonstrated markedly elevated CEA levels, supporting peritoneal carcinomatosis [5]. The final diagnosis confirmed advanced pancreatic adenocarcinoma with direct gastric invasion. The patient declined chemotherapy and was referred to hospice care.

DISCUSSION

Although primary gastric lesions are more common, extrinsic malignancy should be considered when endoscopic findings and pathology are not concordant. In this case, the initial tissue sampling suggested a benign lesion, but the lesion’s morphology and progression raised suspicion. Pancreatic cancers involving the stomach tend to originate from the body or tail and spread via direct extension [6]. Clinically, such lesions can resemble primary gastric ulcers, making evaluation complex.

Tumor markers such as CA 19-9 may not be elevated in all pancreatic cancers; the extremely low CA 19-9 in this patient illustrates that tumor markers alone may not be reliable in excluding pancreatic cancer [7]. Radiological correlation using CT and PET-CT is therefore essential to detect extra-luminal disease [4].

This case supports the use of repeated endoscopic evaluation and imaging when discrepancies between clinical, endoscopic, and histologic findings exist. Biopsies of ulcerative lesions may occasionally miss submucosal or externally infiltrating tumors, especially those of extrinsic origin. This highlights the limitations of superficial tissue sampling and the potential value of advanced techniques such as endoscopic ultrasound-guided fine needle aspiration. 8,9

In conclusion, this case highlights the importance of considering extrinsic malignancy when encountering atypical gastric lesions that are discordant with biopsy findings. A multidisciplinary diagnostic approach that integrates endoscopic morphology, histopathological findings, and cross-sectional imaging is essential to prevent misdiagnosis and ensure timely management.

Notes

Availability of Data and Material

All data generated or analyzed during the study are included in this published article.

Conflicts of Interest

The author has no financial conflicts of interest.

Funding Statement

None

Acknowledgements

The author thanks the Department of Pathology, Semyeong Christianity Hospital, for their support.

Ethics Statement

The patient was deceased at the time of manuscript preparation, and informed consent could not be obtained. All identifying details have been fully anonymized in accordance with ethical standards.

References

1. Maisonneuve P. Epidemiology and burden of pancreatic cancer. Presse Med 2019;48(3 Pt 2):e113–e123.
2. Blastik M, Plavecz E, Zalatnai A. Pancreatic carcinomas in a 60-year, institute-based autopsy material with special emphasis of metastatic pattern. Pancreas 2011;40:478–480.
3. Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol 2018;24:2047–2060.
4. Cannistrà M, Ruggiero M, Zullo A, Serafini S, Grande R, Nardo B. Metastases of pancreatic adenocarcinoma: a systematic review of literature and a new functional concept. Int J Surg 2015;21(Suppl 1):S15–S21.
5. Cho CH, Chung JB, Yim DS, et al. Diagnostic value of carcinoembryonic antigen (CEA) in ascitic fluid. Korean J Med 1986;31:630–637.
6. Feczko PJ, Collins DD, Mezwa DG. Metastatic disease involving the gastrointestinal tract. Radiol Clin North Am 1993;31:1359–1373.
7. Janga LSN, Sambe HG, Yasir M, et al. Holistic understanding of the role of carbohydrate antigen 19-9 in pancreatic cancer screening, early diagnosis, and prognosis: a systematic review. Cureus 2023;15e44382.
8. Ji JS, Lee BI, Choi KY, et al. Diagnostic yield of tissue sampling using a bite-on-bite technique for incidental subepithelial lesions. Korean J Intern Med 2009;24:101–105.
9. Levine I, Trindade AJ. Endoscopic ultrasound fine needle aspiration vs fine needle biopsy for pancreatic masses, subepithelial lesions, and lymph nodes. World J Gastroenterol 2021;27:4194–4207.

Article information Continued

Fig. 1.

Initial screening esophagogastroduodenoscopy. A 1-cm ulcerative lesion with whitish exudate and central depression is noted on the lesser curvature of the upper gastric body.

Fig. 2.

Detailed endoscopic view using cap-fitted endoscope. Central ulceration with surrounding erythema and friable mucosa. Second-look esophagogastroduodenoscopy reveals deeper ulceration with irregular borders and mucosal disruption suggestive of fistulization.

Fig. 3.

Histopathologic examination of the gastric biopsy specimen (H&E stain). A: Irregular infiltrating glands with desmoplastic stroma (×200). B: Densely packed, irregularly branching glandular structures (×200). C: Cribriform patterns of malignant glandular formation (×200). D: Tumor cells showing nuclear hyperchromasia, pleomorphism, and loss of polarity (×400).

Fig. 4.

Contrast-enhanced abdominal computed tomography. Axial view showing an ill-defined hypodense mass in the pancreatic body invading the lesser curvature of the stomach. Coronal view reveals extensive peritoneal carcinomatosis and ascites.

Fig. 5.

Positron emission tomography-computed tomography (PET-CT). Axial fused PET-CT images show intense fluorodeoxyglucose uptake in the pancreatic mass and multiple peritoneal foci.